IP Library Assignment 049209/0272
Patent Assignment
Reel/Frame 049209/0272

Security Interest

Recorded: 2019-05-17 Pages: 14
Assignors
CUTISPHARMA, INC.
Executed: 2019-05-17
SILVERGATE PHARMACEUTICALS, INC.
Executed: 2019-05-17
Assignee
GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
2001 ROSS AVE., SUITE 2800, DALLAS, TEXAS, 75201
Covered Properties (32)
Enalapril Compositions
Lisinopril Formulations
Enalapril Formulations
Composition and Method for Proton Pump Inhibitor Suspension
Apparatus and Method for Filling Bulk Materials into a Container
Amlodipine Formulations
Amlodipine Formulations
Compositions and Kits for Compounding Pharmaceuticals
Patent: 6,708,822 →
Application: 09/707,783 →
Container and Method for the Preparation, Storage and Dispensing of Compounded Suppositories
Patent: 7,434,690 →
Application: 11/093,178 →
Publication: US 2005/0241982
Container and Kit for the Preparation, Storage and Dispensing of Compounded Suppositories
Patent: 7,815,929 →
Application: 12/207,957 →
Publication: US 2009/0028964
Container and Kit for the Preparation, Storage and Dispensing of Compounded Suppositories
Patent: 8,276,757 →
Application: 12/902,260 →
Publication: US 2011/0024322
Enalapril Compositions
Patent: 8,568,747 →
Application: 13/670,355 →
Enalapril Compositions
Patent: 8,778,366 →
Application: 13/914,452 →
Publication: US 2014/0100260
Lisinopril Formulations
Patent: 9,463,183 →
Application: 14/934,752 →
Container and Method for the Preparation, Storage and Dispensing of Compounded Suppositories
Patent: 9,918,903 →
Application: 15/006,745 →
Publication: US 2016/0213567
Enalapril Formulations
Patent: 9,669,008 →
Application: 15/081,603 →
Composition and Method for Vancomycin Oral Liquid
Application: 15/126,059 →
Publication: US 2017/0079910
Lisinopril Formulations
Patent: 9,616,096 →
Application: 15/268,095 →
Publication: US 2017/0119840
Enalapril Compositions
Patent: 9,855,214 →
Application: 15/433,743 →
Publication: US 2017/0181968
Lisinopril Formulations
Patent: 9,814,751 →
Application: 15/483,691 →
Publication: US 2017/0209523
Enalapril Formulations
Patent: 9,808,442 →
Application: 15/613,622 →
Publication: US 2017/0266159
Amlodipine Formulations
Application: 15/726,901 →
Publication: US 2018/0098978
Composition and Method for Vancomycin Oral Liquid
Application: 15/791,717 →
Publication: US 2018/0116955
Enalapril Formulations
Application: 15/802,341 →
Publication: US 2018/0055821
Lisinopril Formulations
Application: 15/805,934 →
Publication: US 2018/0078604
Enalapril Compositions
Patent: 9,968,553 →
Application: 15/850,732 →
Publication: US 2018/0116954
Enalapril Formulations
Application: 16/003,994 →
Publication: US 2018/0289669
Lisinopril Formulations
Application: 16/053,164 →
Publication: US 2018/0339011
Enalapril Formulations
Application: 16/177,159 →
Publication: US 2019/0070147
Enalapril Formulations
Application: 16/242,898 →
Publication: US 2019/0142797
Lisinopril Formulations
Application: 16/295,482 →
Publication: US 2019/0201475
Amlodipine Formulations
Application: 16/381,575 →
Publication: US 2019/0314279
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 11, 2012
From: MUNI, INDU; MUNI, GITA; PATEL, DILIP; MIONE, PETER
To: CUTISPHARMA, INC.
Reel/Frame 028528/0213 →
Assignment of Assignor's Interest Nov 11, 2013
From: BECKLOFF, MICHAEL C.; SEGRAVE, FRANK; MAURO, ROBERT; COLABUONO, PETER
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 031575/0565 →
Assignment of Assignor's Interest Apr 14, 2014
From: RAJEWSKI, LIAN G.; RAJEWSKI, ROGER A.; HASLAM, JOHN L.; HEPPERT, KATHLEEN
To: UNIVERSITY OF KANSAS
Reel/Frame 032665/0954 →
Corrective Assignment to Correct the 1ST Line of Assignee's Address to Read 245 Strong Hall Previously Recorded on Reel 032665 Frame 0954. Assignor(S) Hereby Confirms the Assignment of Assignors Interest. Apr 21, 2014
From: RAJEWSKI, LIAN G.; RAJEWSKI, ROGER A.; HASLAM, JOHN L.; HEPPERT, KATHLEEN
To: UNIVERSITY OF KANSAS
Reel/Frame 032722/0636 →
Security Agreement Dec 16, 2014
From: CUTISPHARMA, INC.; RXEDESIGNEDMEDS, LLC; RXM THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 034648/0882 →
Security Interest Nov 3, 2015
From: SILVERGATE PHARMACEUTICALS, INC.
To: ESCALATE CAPITAL PARTNERS SBIC III, LP
Reel/Frame 036945/0861 →
Assignment of Assignor's Interest Nov 6, 2015
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 037066/0263 →
Security Interest Nov 23, 2015
From: SILVERGATE PHARMACEUTICALS, INC.
To: COMERICA BANK
Reel/Frame 037123/0437 →
Assignment of Assignor's Interest Jan 28, 2016
From: GANDHI, PREMAL; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 037603/0969 →
Assignment of Assignor's Interest Apr 8, 2016
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 038792/0116 →
Assignment of Assignor's Interest Jul 15, 2016
From: GANDHI, PREMAL; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 039169/0025 →
Assignment of Assignor's Interest Sep 16, 2016
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 040066/0323 →
Assignment of Assignor's Interest Jan 5, 2017
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 040863/0993 →
Assignment of Assignor's Interest Feb 16, 2017
From: RAJEWSKI, LIAN G.; RAJEWSKI, ROGER A.; HASLAM, JOHN L.; HEPPERT, KATHLEEN
To: UNIVERSITY OF KANSAS
Reel/Frame 041278/0887 →
Assignment of Assignor's Interest Feb 16, 2017
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CHRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 041268/0247 →
Assignment of Assignor's Interest Feb 16, 2017
From: BECKLOFF, MICHAEL C.; SEGRAVE, FRANK; MAURO, ROBERT; COLABUONO, PETER
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 041278/0264 →
Corrective Assignment to Correct the the Misspelling of Inventor Name Previously Recorded at Reel: 041268 Frame: 0247. Assignor(S) Hereby Confirms the Assignment. Mar 29, 2017
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 042108/0659 →
Assignment of Assignor's Interest Mar 31, 2017
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 041809/0993 →
Assignment of Assignor's Interest Apr 19, 2017
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 042097/0015 →
Assignment of Assignor's Interest Jun 13, 2017
From: MOSHER, GEROLD L.; MILES, DAVID W.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 042786/0848 →
Assignment of Assignor's Interest Aug 9, 2017
From: FALLIN, KEN; RENAUD, KAITY; MIONE, PETER; MUNI, NEAL
To: CUTISPHARMA, INC.
Reel/Frame 043242/0603 →
Assignment of Assignor's Interest Oct 13, 2017
From: BRAUER, SCOTT; MOSHER, GEROLD L
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 043864/0333 →
Assignment of Assignor's Interest Oct 13, 2017
From: BRAUER, SCOTT; MOSHER, GEROLD L.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 043866/0190 →
Assignment of Assignor's Interest Nov 9, 2017
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 044079/0932 →
Release of Security Interest Dec 28, 2017
From: ESCALATE CAPITAL PARTNERS SBIC III, LP
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 044498/0193 →